SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biofield may double within 3 months!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: damniseedemons who wrote (69)1/29/1997 1:34:00 AM
From: Mike Winn   of 120
 
Sal,

Do you know why Biofield did not present the Europe test data at the H&Q
conference? According to their prospectus, they are supposed to launch
the sale to Europe by now. Do you see any sign that it is going to
happen soon? Is Biofield behind schedule? I used to work for a
bio-medical company and 510K approval can take as little as 6 months
for medical equipments using existing technology. With new tech., it
usually takes longer. Do you think with the expedite status, approval
for Biofield's equipment will take only 6 months? Have you contacted
the company? Please let me know if you have any information besides
looking at the stock chart.

Thanks,
Mike.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News